Literature DB >> 1993477

Hemolytic activity of adenylate cyclase toxin from Bordetella pertussis.

I E Ehrmann1, M C Gray, V M Gordon, L S Gray, E L Hewlett.   

Abstract

Adenylate cyclase (AC) toxin from B. pertussis enters eukaryotic cells where it produces supraphysiologic levels of cAMP. Purification of AC toxin activity [(1989) J. Biol. Chem. 264, 19279] results in increasing potency of hemolytic activity and electroelution of the 216-kDa holotoxin yields a single protein with AC enzymatic, toxin and hemolytic activities. AC toxin and E. coli hemolysin, which have DNA sequence homology [(1988) EMBO J. 7, 3997] are immunologically cross-reactive. The time courses of hemolysis elicited by the two molecules are strikingly different, however, with AC toxin eliciting cAMP accumulation with rapid onset, but hemolysis with a lag of greater than or equal to 45 min. Finally, osmotic protection experiments indicate that the size of the putative pore produced by AC toxin is 3-5-fold smaller than that of E. coli hemolysin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993477     DOI: 10.1016/0014-5793(91)80088-k

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  39 in total

1.  Stimulation of Bordetella pertussis adenylate cyclase toxin intoxication by its hemolysin domain.

Authors:  M Iwaki; K Kamachi; T Konda
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

2.  Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin.

Authors:  S J Lee; M C Gray; L Guo; P Sebo; E L Hewlett
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Aggregatibacter actinomycetemcomitans leukotoxin cytotoxicity occurs through bilayer destabilization.

Authors:  Angela C Brown; Kathleen Boesze-Battaglia; Yurong Du; Frank P Stefano; Irene R Kieba; Raquel F Epand; Lazaros Kakalis; Philip L Yeagle; Richard M Epand; Edward T Lally
Journal:  Cell Microbiol       Date:  2012-03-28       Impact factor: 3.715

Review 4.  Bordetella adenylate cyclase toxin: a unique combination of a pore-forming moiety with a cell-invading adenylate cyclase enzyme.

Authors:  Jiri Masin; Radim Osicka; Ladislav Bumba; Peter Sebo
Journal:  Pathog Dis       Date:  2015-09-20       Impact factor: 3.166

5.  Characterization of serological responses to pertussis.

Authors:  Mineo Watanabe; Beverly Connelly; Alison A Weiss
Journal:  Clin Vaccine Immunol       Date:  2006-03

6.  Differences in purinergic amplification of osmotic cell lysis by the pore-forming RTX toxins Bordetella pertussis CyaA and Actinobacillus pleuropneumoniae ApxIA: the role of pore size.

Authors:  Jiri Masin; Radovan Fiser; Irena Linhartova; Radim Osicka; Ladislav Bumba; Erik L Hewlett; Roland Benz; Peter Sebo
Journal:  Infect Immun       Date:  2013-09-30       Impact factor: 3.441

7.  Characterization of binding of adenylate cyclase toxin to target cells by flow cytometry.

Authors:  M C Gray; W Ross; K Kim; E L Hewlett
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

8.  Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence.

Authors:  M K Gross; D C Au; A L Smith; D R Storm
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

9.  Structure-function studies of the adenylate cyclase toxin of Bordetella pertussis and the leukotoxin of Pasteurella haemolytica by heterologous C protein activation and construction of hybrid proteins.

Authors:  G Westrop; K Hormozi; N da Costa; R Parton; J Coote
Journal:  J Bacteriol       Date:  1997-02       Impact factor: 3.490

10.  Cloning and characterization of btr, a Bordetella pertussis gene encoding an FNR-like transcriptional regulator.

Authors:  J D Bannan; M J Moran; J I MacInnes; G A Soltes; R L Friedman
Journal:  J Bacteriol       Date:  1993-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.